In a bid to aggressively tap the growing probiotics market in India, Morepen Laboratories has reportedly entered into partnership with Belgium’s Vesale Pharma. The move is expected to contribute Rs 100 crore to the Indian company’s topline in five years. Moreover, the company will soon be launching four major probiotics developed by Vesale Pharma in the Indian market.
Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.
